Veterinary Medicines

Bisolvon 10mg/g Oral Powder

Authorised
  • Bromhexine hydrochloride
Download as PDF

Product identification

Medicine name:
Bisolvon 10mg/g Oral Powder
Active substance:
  • Bromhexine hydrochloride
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Bromhexine hydrochloride
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        2
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05CB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • High density polyethylene jars with HDPE screw caps and PVC-faced cork wadcontaining 500 g powder and a 5 g white polystyrene measuring spoon.
  • High density polyethylene jars with HDPE screw caps and PVC-faced cork wadcontaining 100 g powder and a 5 g white polystyrene measuring spoon.
  • Paper/aluminium foil laminate sachets (heat sealed) containing 5 g powder. Boxes of 40 sachets also contain 0.5 g blue polystyrene measuring spoons.
  • High density polyethylene jar with push-fit polyethylene cap containing 1000 gpowder and a 5 g white polystyrene measuring spoon.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Klocke Pharma-Service GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/002/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."